Beacon Hill Strategy Group
We are trusted advisors to a select group of CEOs, serving as their fractional strategy team.
What we do
We help CEOs sharpen their strategies to improve financial performance, align capital and execution, and drive sustained enterprise value creation.
We help CEOs use M&A as a repeatable engine for enterprise value creation, from strategy through integration and capability building.
We help CEOs identify, design, and launch new business models and ventures that create differentiated, scalable sources of growth.
Our model
We are trusted advisors to a select group of CEOs as their fractional strategy team.
We provide the insight, analysis, and honest perspective they can’t find anywhere else.
Enterprise strategy
After a major strategic pivot, leadership faced growing disconnect between strategy, capital allocation, and market perception. We helped the CEO realign the enterprise narrative, sharpen the growth engine, and restore confidence with the board and investors, creating a clear path to value creation.
M&A and integration
An acquisition anchored in extending competitive advantage and realizing synergies was struggling to meet milestones and deliver real value. We helped leadership reset integration priorities, clarify true value drivers, and reposition the story with the board, transforming integration from a defensive exercise into a strategic lever.
Growth and new ventures
Having clarified a sharp enterprise strategy for long-term growth, leadership needed to translate ambition into action. We helped the executive team identify, prioritize, and sequence a focused portfolio of growth initiatives, rapidly making progress on key initiatives and ensuring innovation efforts reinforced enterprise strategy.
Managing Partner
25+ years helping CEOs drive transformative growth and execute complex M&A. Former Chief Strategy Officer of Valo Health, Innosight partner advising biotech and healthcare companies, and Halozyme Therapeutics board director, with earlier senior roles at IBM and McKinsey.
Read more
Partner
Former head of corporate strategy and development at Valo Health, an AI-enabled drug discovery company, with earlier roles at Mass General Brigham's Data Science Office and Innosight.
Read moreFeatured insights
Explore our latest thinking on growth strategies, acquisitions, and navigating value inflection points.
M&A
Mergers and acquisitions (M&A) can be transformative for growth and innovation when aligned with long-term strategy, managed with financial discipline, and supported by strong leadership and robust performance management to ensure sustainable value creation.
M&A, Strategy
Developing a successful enterprise AI strategy requires aligning AI initiatives with industry realities, leveraging existing value chains, prioritizing data strategy, embracing iterative growth, and building feedback loops for continuous improvement to unlock sustainable competitive advantage.
M&A
Flywheel strategies create sustainable growth and competitive advantage by aligning interconnected actions, fostering momentum, and adapting to challenges with deliberate strategic choices and customer-centric approaches.
As your trusted advisors and fractional strategy team, we help you navigate complexity and deliver results that enhance value and build a legacy.